Fundraising Fox
Sequence Bio
YC S19St. John's, CA · Founded 2013 · 52 employees · 8 known investors
Find your way into Sequence Bio
Sign up to see every warm intro you have to Sequence Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sequence Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sequence Bio discovers genetic causes of disease within Newfoundland and Labrador's founder population to develop breakthrough treatments, diagnostics, and preventions. The company focuses on translational biology and genetics research for patients globally.
Also known as Sequence Bioinformatics Inc.
Founders & leadership· Y Combinator alumni (S19)
Sequence Bio was founded in 2013 by Jeremy Grushcow and Chris Gardner.
Investors · 8
How we know: C3 Ventures's portfolio page · Not right? Tell us
How we know: funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us
How we know: Killick Capital's portfolio page · Y Combinator's founder network · Not right? Tell us
How we know: Pelorus Venture Capital's portfolio page · Not right? Tell us
How we know: westerntech.com · Not right? Tell us
How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$2.9M disclosed across 2 rounds · 2016–2019
▶$1.3MraisedJul 2019 · 2 investors · OtherRule 506(b)
- CHRIS GARDNERExecutive Officer, Director
- JAMES HARDIMANDirector
- ANDREW FUREYDirector
- MARK DOBBINDirector
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- Jul 2019
- Incorporated
- Corporation, Newfoundland, Canada
- Federal exemptions
- 06b
▶$1.6MraisedJul 2016 · 1 investors · OtherRule 506(b)
- Tyler WishExecutive Officer, Director
- Chris GardnerExecutive Officer, Director, Promoter
- James HardimanDirector
- Andrew FureyDirector
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- First sale
- Jun 2016
- Incorporated
- Corporation, Newfoundland, Canada, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Sequence Bio went on to found or lead other companies.
Related companies · 8
Companies working in the same space as Sequence Bio.
Legal entities · 1
corporate structureFrequently asked questions
- What does Sequence Bio do?
- Sequence Bio discovers genetic causes of disease within Newfoundland and Labrador's founder population to develop breakthrough treatments, diagnostics, and preventions. The company focuses on translational biology and genetics research for patients globally.
- Who founded Sequence Bio?
- Sequence Bio was founded by Jeremy Grushcow, Chris Gardner in 2013.
- Who are Sequence Bio's investors?
- Sequence Bio's investors include C3 Ventures, DCVC (Data Collective), Killick Capital, Pelorus Venture Capital, Western Technology Investment, Y Combinator, Heron Rock AL Access Funds, Venture Newfoundland and Labrador.
- How much funding has Sequence Bio raised?
- Sequence Bio has disclosed $2.9M raised across 2 rounds.
- Where is Sequence Bio headquartered?
- Sequence Bio is headquartered in St. John's, CA.